Downloadable
CONNECT Trial Infographic
A visual summary of CONNECT trial results for Dexcom CGM in type 2 diabetes not treated with insulin.
Image
This resource is intended for educational purposes only for healthcare providers practicing in the United States. It does not constitute medical advice and is not a substitute for professional judgment or individualized patient care.
Evidence summaries for real-world care
CONNECT Trial Infographic
Download for easy reference, printing, or sharing with your care team.
References
- Martens, T. Presented at American Diabetes Association 2026 Scientific Sessions, June 6, 2026; New Orleans, LA; USA.
- Reed J, Dong T, Eaton E, et al. Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial. Diabetes Obes Metab. 2024;26(7):2881-2889. doi:10.1111/dom.15608
- Beck RW, Bergenstal RM, Riddlesworth TD, et al. Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes Care. 2019;42(3):400-405. doi:10.2337/dc18-1444
- Shah VN, Kanapka LG, Akturk HK, et al. Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study. Diabetes Technol Ther. 2024;26(4):246-251. doi:10.1089/dia.2023.0486
- Kovatchev BP, Lobo B, Fabris C, et al. The Virtual DCCT: Adding Continuous Glucose Monitoring to a Landmark Clinical Trial for Prediction of Microvascular Complications. Diabetes Technol Ther. 2025;27(3):209-216. doi:10.1089/dia.2024.0404